Cystatin C as a marker of cognitive function in elders: Findings from the Health ABC Study

Annals of Neurology

Volumn 63, Issue 6, 2008, Pages 798-802

  Yaffe, Kristine ^a,g   Lindquist, Karla ^a   Shlipak, Michael G ^a   Simonsick, Eleanot ^b   Fried, Linda ^c   Rosano, Caterina ^d   Satterfield, Suzanne ^e   Atkinson, Hal ^f   Windham, B Gwen ^b   Kurella Tamura, Manjula ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CYSTATIN C;

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIGIT SYMBOL SUBSTITUTION TEST; ELDERLY CARE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AGE DISTRIBUTION; AGED; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BODY MASS INDEX; BRAIN; COGNITION DISORDERS; COMORBIDITY; CONTINENTAL POPULATION GROUPS; CYSTATINS; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEYS; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MEMORY DISORDERS; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SMOKING;

EID: 46749085524     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21383     Document Type: Article

References (20)

1. Sastre M, Calero M, Pawlik M, et al. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging 2004;25:1033-1043.
2. Finckh U, von der Kammer H, Velden J, et al. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol 2000;57:1579-1583.
3. Chuo LJ, Sheu WH, Pai MC, Kuo YM. Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease. Dement Geriatr Cogn Disord 2007;23:251-257.
4. Simonsick EM, Newman AB, Nevitt MC, et al. Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci 2001;56:M644-M649.
5. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
6. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation, 1997.
7. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 1999;59:1-8.
8. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-2060.
9. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
10. K/DOQ1 clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
11. McManus D, Shlipak M, Ix JH, et al. Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study. Am J Kidney Dis 2007;49:365-372.
12. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 2005;142:497-505.
13. Levey AS, Greene T, Sarnak MJ, et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 2006;48:879-888.
14. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol 2004;15:1904-1911.
15. Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 2004;52:1863-1869.
16. Kurella M, Yaffe K, Shlipak MG, et al. Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis 2005;45:66-76.
17. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005;16:2127-2133.
18. Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005;16:1404-1412.
19. Seliger SL, Longstreth WT Jr, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol 2005;16:3721-3727.
20. Deng A, Irizarry MC, Nitsch RM, et al. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J Pathol 2001;159:1061-1068.